Sztark F, Gékière J P, Dabadie P
Département des urgences, hôpital Pellegrin, Bordeaux, France.
Ann Fr Anesth Reanim. 1997;16(3):282-91. doi: 10.1016/s0750-7658(97)86412-x.
Haemodynamic effects of hypertonic saline solutions (HSS) have been extensively studied in animals and humans. Hypertonic sodium chloride (7.5%, 2,500 mOsm.L-1) either alone or combined with colloids, remains the standard solution. The haemodynamic response of HSS observed during treatment of hypovolaemic shock is explained by 1) an increase in preload due to the expansion of the plasma volume and a musculocutaneous vasoconstriction and 2) a decrease in systemic vascular resistance and afterload. A myocardial stimulation has been shown in various experimental conditions and in humans. However, the clinical relevance of this inotropic effect is questionable. Haemorrhagic shock is the main indication for small volume resuscitation with HSS. Other potential situations for the use of HSS are volume replacement in perioperative period, septic shock or burn injury and cardiopulmonary resuscitation. Before recommending the clinical use of HSS, additional clinical studies are required to substantiate the benefits of HSS over colloids.
高渗盐溶液(HSS)的血流动力学效应已在动物和人类中得到广泛研究。高渗氯化钠(7.5%,2500 mOsm.L-1)单独使用或与胶体联合使用,仍然是标准溶液。在低血容量性休克治疗期间观察到的HSS血流动力学反应可解释为:1)由于血浆容量扩张和肌皮血管收缩导致前负荷增加;2)全身血管阻力和后负荷降低。在各种实验条件下和人体中均已显示出心肌刺激作用。然而,这种正性肌力作用的临床相关性值得怀疑。失血性休克是使用HSS进行小容量复苏的主要指征。使用HSS的其他潜在情况包括围手术期的容量替代、感染性休克或烧伤以及心肺复苏。在推荐临床使用HSS之前,需要进行更多的临床研究以证实HSS优于胶体的益处。